Cargando…
Differential Mutation Detection Capability Through Capture-Based Targeted Sequencing in Plasma Samples in Hepatocellular Carcinoma
Circulating tumor DNA (ctDNA) is a promising biomarker for accurate monitoring and less invasive assessment of tumor burden and treatment response. Here, targeted next-generation sequencing (NGS) with a designed gene panel of 176 cancer-relevant genes was used to assess mutations in 90 ctDNA samples...
Autores principales: | Gao, Jian, Xi, Lei, Yu, Rentao, Xu, Huailong, Wu, Min, Huang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120297/ https://www.ncbi.nlm.nih.gov/pubmed/33996539 http://dx.doi.org/10.3389/fonc.2021.596789 |
Ejemplares similares
-
Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients
por: Zhang, Hui, et al.
Publicado: (2023) -
Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma
por: Lin, Zhuo, et al.
Publicado: (2022) -
Detection of KRAS mutation using plasma samples in non-small-cell lung cancer: a systematic review and meta-analysis
por: Cai, Peiling, et al.
Publicado: (2023) -
Identifying Actionable Variants Using Capture-Based Targeted Sequencing in 563 Patients With Non-Small Cell Lung Carcinoma
por: Jiang, Haiping, et al.
Publicado: (2022) -
Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung Cancer
por: Zhang, Xinyu, et al.
Publicado: (2021)